BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 117851
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.117851
Table 1 Clinical characteristic of esophageal patients, median (interquartile range)/mean (SD)
Variables
Whole cohort (n = 206)
Training cohort (n = 144)
Validation cohort (n = 62)
P value
Age 64.1 (7.5)64.5 (7.5)63.1 (7.4)0.218
Gender0.570
Female45 (21.8%)33 (22.9%)12 (19.4%)
Male161 (78.2%)111 (77.1%)50 (80.6%)
Body mass index23.1 (2.65)23.1 (2.7)23.1 (2.5)0.965
Smoking and drinking0.267
None86 (41.7%)60 (41.7%)26 (41.9%)
Smoking alone40 (19.4%)29 (20.1%)11 (17.7%)
Drinking alone13 (6.3%)6 (4.2%)7 (11.3%)
Both67 (32.5%)49 (34%)18 (29%)
Squamous cell carcinoma level1 (0.6, 1.4)1 (0.6, 1.4)1.1 (0.8, 1.3)0.520
Cytokeratin 19 fragment antigen 21-1 level1.4 (0.9, 1.8)1.4 (0.9, 1.9)1.3 (0.8, 1.8)0.290
Carcinoembryonic antigen level3.4 (2.6, 4.3)3.4 (2.6, 4.4)3.5 (2.6, 4.2)0.924
Carbohydrate antigen 19922.3 (14.9, 29.7)22.5 (14.8, 30)22.2 (16.8, 27.2)0.828
Tumor location0.480
Upper63 (30.6%)44 (30.6%)19 (30.6%)
Middle130 (63.1%)89 (61.8%)41 (66.1%)
Lower13 (6.3%)11 (7.6%)2 (3.2%)
Tumor length3 (2, 4.5)3.4 (2, 4.5)3 (2, 4)0.082
Computed tomography-reported nodal status0.407
Negative148 (71.8%)101 (70.1%)47 (75.8%)
Positive58 (28.2%)43 (29.9%)15 (24.2%)
Tumor grade0.057
G116 (7.8%)7 (4.9%)9 (14.5%)
G2150 (72.8%)109 (75.7%)41 (66.1%)
G340 (19.4%)28 (19.4%)12 (19.4%)
Depth of tumor invasion0.912
cT147 (22.8%)33 (22.9%)14 (22.6%)
cT258 (28.2%)40 (27.8%)18 (29%)
cT391 (44.2%)63 (43.8%)28 (45.2%)
cT410 (4.9%)8 (5.6%)2 (3.2%)
Node stage0.506
pN0127 (61.7%)89 (61.8%)38 (61.3%)
pN146 (22.3%)35 (24.3%)11 (17.7%)
pN219 (9.2%)12 (8.3%)7 (11.3%)
pN314 (6.8%)8 (5.6%)6 (9.7%)
Lymph node metastasis status0.944
Negative127 (61.7%)89 (61.8%)38 (61.3%)
Positive79 (38.3%)55 (38.2%)24 (38.7%)


Write to the Help Desk